- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Novartis division Sandoz inaugurates facility in Maharashtra for oral cancer medicines
The plant, which is spread over 32,000 square metres, would cater to the export markets, it added.
New Delhi: Drug firm, Novartis India, has recently announced that the company's division Sandoz Technical Operations has inaugurated a new manufacturing facility in Maharashtra.The plant at Kalwe would produce oral cancer medicines for the global markets and will play a key role towards enabling the delivery of high-quality cancer treatment, the drug maker said in a statement. The plant, which...
New Delhi: Drug firm, Novartis India, has recently announced that the company's division Sandoz Technical Operations has inaugurated a new manufacturing facility in Maharashtra.
Sanjay Murdeshwar, Country President, Novartis India said, "This marks an important milestone for us at Novartis, and particularly for our Sandoz division, a global leader in generic pharmaceuticals and biosimilars. The inauguration of the new production and launch site for Oncology oral solids at Kalwe in India is a step forward in our constant endeavour to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs. Moreover, the launch of this facility will support the government's 'Make in India' vision to find solutions for the evolving needs of patients around the world."
Novartis has three legal entities -- Novartis Healthcare Pvt Ltd, Novartis India and Sandoz Pvt Ltd, employing more than 10,000 people.
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751